Navigation Links
Battle between the placenta and uterus could help explain preeclampsia

A battle that brews in the mother's womb between the father's biological goal to produce the biggest, healthiest baby possible vs. the mother's need to live through delivery might help explain preeclampsia, an often deadly disease of pregnancy. The fetus must be big enough to thrive, yet small enough to pass through the birth canal. In a new study, Yale researchers describe the mechanism that keeps these conflicting goals in balance.

The findings are published in the October 11, 2011 online issue of Reproductive Sciences.

The battle is waged between the mother's uterus and the baby's placenta, which is made up of cells called trophoblasts that are controlled by the father. In the study, led by Harvey J. Kliman, M.D., research scientist in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale School of Medicine, researchers observed how the placenta tricks the mother so she doesn't attack the trophoblasts that are trying to increase the flow of her blood into the placenta. If this placental deception doesn't work the mother may develop preeclampsia, a condition that results in high blood pressure and protein in the mother's urine. The only known cure for preeclampsia is delivery of the baby.

The placenta's job is to get nutrients from the mother during pregnancy. Kliman explained that in a normal pregnancy, specialized invasive trophoblasts leave the placenta and invade the mother's tissues to attack and destroy the walls of her blood vessels. This allows the most blood possible to enter the placenta, resulting in a big baby.

But the mother's own "soldiers," called lymphocytes, are constantly looking to destroy the invasive trophoblast cells. The placenta in turn appears to trick the mother by creating a diversion to occupy her lymphocytes.

The placenta creates this diversion by secreting a protein called placental protein 13 (PP13), also known as galectin 13, into the mother's blood where it travels through her veins into the uterus below the placenta. There the PP13 leaves the veins where it triggers the mother's immune system to react and attack. The entire area around these veins becomes a mass of inflammation and dead cells, called necrosis.

"We realized that these zones of necrosis are likely occupying the mother's soldiers while the invasive trophoblasts sneak into her arteries, leading to more blood flow to the placenta and a bigger baby," said Kliman. "We believe that maintaining this balance could be the key to a healthy pregnancy free from preeclampsia."


Contact: Karen N. Peart
Yale University

Related medicine news :

1. Explorers Bounty Puffed Fruit Snacks Helping Parents Battle Summer Obesity
2. Battlefield camaraderie yields long-term dividends for veterans, study finds
3. Gourmet Diet Delivery Unites with First Lady's Battle Against Obesity The Fresh Diet Begins Delivering Meals to DC
4. As Health Reform Summit Looms, Battle Lines Are Drawn
5. Barcode Joins the Battle of the Bulge in New iPhone App
6. Little City Foundation Battles for Rights of Individuals with Disabilities in Springfield and Meets with Legislators Day Before Governors Budget Address
7. BATTLE links potential biomarkers to drugs for lung cancer
8. LeAnn Rimes Brings Battle With Psoriasis to Center Stage
9. KidsHealth Challenges App Developers to Battle Obesity
10. Tastier MRE: Chemistry gives battlefield chow a gourmet flare
11. Broccoli May Help Battle Breast Cancer
Post Your Comments:
Related Image:
Battle between the placenta and uterus could help explain preeclampsia
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA Training ... Institute Education Center headquartered in Northern California, has issued an important reminder to ... their worksites. Employers with workers exposed to high temperatures should establish a ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: